Xuan Wang

Dr. Xuan Wang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cytokine
Verified
Journal Article
Closed access
LGLi-Juan Guan
Li-Juan Guan
XWXuan Wang
Xuan Wang
SMShuai Meng
Shuai Meng
LSLiang-Feng Shi
Liang-Feng Shi
WJWen-Juan Jiang
Wen-Juan Jiang
JZJinan Zhang
Jinan Zhang

1 February 2015 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
DLDongmin Li
Dongmin Li
XWXuan Wang
Xuan Wang
XLXi Lan
Xi Lan
YLYue Li
Yue Li
LLLi Liu
Li Liu
SLShemin Lu
Shemin Lu

9 October 2021 in Rheumatology and Therapy
Verified
Journal Article
Open access
PDF file
BLBo Li
Bo Li
JYJunqing Yan
Junqing Yan
JPJincheng Pu
Jincheng Pu
JTJianping Tang
Jianping Tang
SXShuchang Xu
Shuchang Xu
XWXuan Wang
Xuan Wang
Esophageal motility disorders are prevalent in 90% of patients with systemic sclerosis [scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal involvement. Esophageal smooth muscle damage caused by ischemia, nerve damage, and inflammatory factors may be responsible for discomfort and various complications in these patients. The clinical manifestations are diverse. Most hospitals still use traditional esophageal manometry and 24-h pH monitoring to diagnose esophageal function in patients with SSc. The aim of this review article is to provide an overview of SSc‐related esophageal motility disorders and related research progress, including the pathogenesis and clinical features of these disorders and the progress made in endoscopic diagnosis. We also discuss the possible pathogenesis and potential therapeutic targets.

1 September 2011 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
DLDongmin Li
Dongmin Li
XWXuan Wang
Xuan Wang
WRWuchao Ren
Wuchao Ren
JRJuan Ren
Juan Ren
XLXi Lan
Xi Lan
SLShemin Lu
Shemin Lu

11 February 2025 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Open access
PDF file
KCKeni Chang
Keni Chang
PLPeiming Luo
Peiming Luo
ZGZizhen Guo
Zizhen Guo
LYLufei Yang
Lufei Yang
JPJincheng Pu
Jincheng Pu
XWXuan Wang
Xuan Wang
Sjögren’s syndrome (SS) is a chronic autoimmune disorder that primarily affects the exocrine glands. Due to the intricate nature of the disease progression, the exact mechanisms underlying SS are not completely understood. Recent research has highlighted the complex interplay between immune dysregulation and metabolic abnormalities in inflammatory diseases. Notably, lipid metabolism has emerged as a crucial factor in the modulation of immune function and the progression of autoimmune diseases, including SS. This review explores the prevalence of dyslipidemia in SS, emphasizing its role in the onset, progression, and prognosis of the disease. We specifically described the impact of altered lipid metabolism in exocrine glands and its association with disease-specific features, including inflammation and glandular dysfunction. Additionally, we discussed the potential clinical implications of lipid metabolism regulation, including the role of polyunsaturated fatty acids (PUFAs) and their deficits in SS pathogenesis. By identifying lipid metabolism as a promising therapeutic target, this review highlights the need for further research into lipid-based interventions for the management of SS.

1 November 2015 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
XWXuan Wang
Xuan Wang
MWMeichen Wang
Meichen Wang
HLHongmin Li
Hongmin Li
XLXi Lan
Xi Lan
LLLi Liu
Li Liu
DLDongmin Li
Dongmin Li